Trial intelligence / Profile preview

Thermoresponsive ciprofloxacin + dexamethasone ear gel for otitis externa

ACTRN12618001896268Phase 2Completed

Sponsor
The University of Queensland
Start
Sep 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of ciprofloxacin and dexamethasone in external otitis, sponsored by The University of Queensland. Primary endpoints: Time to resolution and Clinical cure. Started Sep 2019; status: completed.

02

Drugs

ciprofloxacindexamethasone
03

Conditions

external otitis

Beyond the preview

Go deeper on ACTRN12618001896268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618001896268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call